trial · primary record
Ixazomib Citrate
Kaposi Sarcoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 41 |
| Primary completion | 2029-03-15 |
| Primary endpoint | Overall response rate |
| Registry ID | NCT04305691 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:05.208Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04305691
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.